Regulation of Cbfa1 expression by total flavonoids of Herba Epimedii

Endocrine Journal

Volumn 53, Issue 1, 2006, Pages 87-94

  Qian, Guofeng ^a   Zhang, Xiuzhen ^a   Lu, Lixia ^b   Wu, Xinjiang ^c   Li, Shumei ^a   Meng, Jian ^a  

^a TONGJI UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Core binding factor 1; Osteoporosis; Total flavonoids of Herba epimedii

Indexed keywords

ESTRIOL; FLAVONOID; ICARIIN; MESSENGER RNA; NILESTRIOL; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE; CHINESE MEDICINE; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; HERBA EPIMEDII; IN VIVO STUDY; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARIECTOMY; PROTEIN EXPRESSION; RAT;

ANIMALS; BONE DENSITY; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIMEDIUM; ESTRADIOL; FEMALE; FLAVONOIDS; GENE EXPRESSION REGULATION; OSTEOBLASTS; OSTEOCALCIN; OSTEOPOROSIS; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKULL; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 33644993478     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.53.87     Document Type: Article

References (20)

1. Xie F, Wu CF, Lai WP, Yang XJ, Cheung PY, Yao XS, Leung PC, Wong MS (2005) The osteoprotective effect of Herba epimedii (HEP) extract in vivo and in vitro. Evid Based Complement Alternat Med 2: 353-361.
2. Meng FH, Li YB, Xiong ZL, Jiang ZM, Li FM (2005) Osteoblastic proliferative activity of Epimedium brevicornum Maxim. Phytomedicine 12: 189-193.
3. Qin L, Zhang G, Hung WY, Shi Y, Leung K, Yeung HY, Leung P (2005) Phytoestrogen-rich herb formula "XLGB" prevents OVX-induced deterioration of musculoskeletal tissues at the hip in old rats. J Bone Miner Metab 23 Suppl: 55-61.
4. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G (1997) Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89: 747-754.
5. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T (1997) Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89: 755-764.
6. Ducy P, Starbuck M, Priemel M, Shen J, Pinero G, Geoffroy V, Amling M, Karsenty G (1999) A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev 13: 1025-1036.
7. Xin ZC, Kim EK, Lin CS, Liu WJ, Tian L, Yuan YM, Fu J (2003) Effects of icariin on cGMP-specific PDE5 and cAMP-specific PDE4 activities. Asian J Androl 5: 15-18.
8. Rasmussen R (2001) Quantification on the Light-Cycler® instrument. Methods and Applications. Springer Press, Heidelberg, pp. 21-34.
9. Bustin SA (2002) Quantification of mRNA using realtime reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol 29: 23-39.
10. Lin JT, Lane JM (2004) Osteoporosis: a review. Clin Orthop 126-134.
11. Jerome CP (2004) Hormonal therapies and osteoporosis. ILAR J 45: 170-178.
12. Zhou S, Zilberman Y, Wassermann K, Bain SD, Sadovsky Y, Gazit D (2001) Estrogen modulates estrogen receptor alpha and beta expression, osteogenic activity, and apoptosis in mesenchymal stem cells (MSCs) of osteoporotic mice. J Cell Biochem 81: 144-155.
13. Dang ZC, Van Bezooijen RL, Karperien M, Papapoulos SE, Lowik CW (2002) Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis. J Bone Miner Res 17: 394-405.
14. Plant A, Samuels A, Perry MJ, Colley S, Gibson R, Tobias JH (2002) Estrogen-induced osteogenesis in mice is associated with the appearance of Cbfa1-expressing bone marrow cells. J Cell Biochem 84: 285-294.
15. Lecka-Czernik B, Gubrij I, Moerman EJ, Kajkenova O, Lipschitz DA, Manolagas SC, Jilka RL (1999) Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2. J Cell Biochem 74: 357-371.
16. Yamaguchi A, Komori T, Suda T (2000) Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr Rev 21: 393-411.
17. Gori F, Thomas T, Hicok KC, Spelsberg TC, Riggs BL (1999) Differentiation of human marrow stromal precursor cells: bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation. J Bone Miner Res 14: 1522-1535.
18. Fujiwara M, Tagashira S, Harada H, Ogawa S, Katsumata T, Nakatsuka M, Komori T, Takada H (1999) Isolation and characterization of the distal promoter region of mouse Cbfa1. Biochim Biophys Acta 1446: 265-272.
19. Banerjee C, McCabe LR, Choi JY, Hiebert SW, Stein JL, Stein GS, Lian JB (1997) Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J Cell Biochem 66: 1-8.
20. Fujita T, Fukuyama R, Izumo N, Hirai T, Meguro T, Nakamuta H, Koida M (2001) Transactivation of core binding factor alpha1 as a basic mechanism to trigger parathyroid hormone-induced osteogenesis. Jpn J Pharmacol 86: 405-416.